Alzheimer's
0 causal edges 12 causal effects 12 hypotheses 0 open gaps 8 papers
Causal-edge map (sample)
Explore in Knowledge Graph →Inner ring = highest depth_score (out-edges − in-edges). Outer ring = next-most-upstream. Edge thickness = claimed confidence.
Top causal effects
Quantitative effect-size rows from substrate_causal_effects (Q-CAUSAL Phase 1). Sorted by |effect_size| desc.
- pathway beta_amyloid → disease alzheimer_disease — p n/a LLM_inferred
- disease Alzheimer's_disease → process synaptic_loss — p n/a LLM_inferred
- cell Netrin-1-Engineered Endothelial Cell Exosomes → pathway Focal Adhesion — p n/a LLM_inferred
- drug CXCR3 blockade → mechanism white matter preservation — p n/a LLM_inferred
- pathway Complement Cascade → disease Neuromyelitis Optica — p n/a LLM_inferred
- mechanism noradrenaline depletion → mechanism synaptic deficits — p n/a LLM_inferred
- mechanism oligodendrocyte sulfatide deficiency → disease AD-like neuroinflammation — p n/a LLM_inferred
- drug NAD+ supplementation → mechanism mitophagy enhancement — p n/a LLM_inferred
- protein Amyloid-Beta (Aβ) → disease Alzheimer'S Disease — p n/a LLM_inferred
- hypothesis h-7ed5dae4 → disease AD — p n/a LLM_inferred
Upstream-target candidates
Ranked by depth_score = out-edges − in-edges. High score = strong upstream signal.
- protein:Amyloid-Beta (Aβ) +1 0 mentions
- pathway:beta_amyloid +1 0 mentions
- variant:APOE4 mutation +1 0 mentions
Leading hypotheses
- Alpha-theta entrainment therapy to enhance default mode network coherence
- Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via glymphatic enhancement and amyloid clearance from PV interneurons in Alzheimer's disease
- ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matter Degeneration in Alzheimer's Disease
- 40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Selectively Eliminate Disease-Associated Microglia
- ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligodendrocytes Underlies White Matter Degeneration in Alzheimer's Disease
- TREM2-APOE4 Co-targeting — Simultaneous Correction of Lipid Sensing and Clearance Deficits
- GFAP-Positive Reactive Astrocyte Subtype Delineation
- APOE Isoform Expression Across Glial Subtypes
- SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK1/Parkin Mitophagy Dysfunction
- Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in Amyloid Phase, Antagonist in Tau Phase
- TREM2-DAP12 Signalosome Enhancement — Boosting PI3K-AKT-mTOR Axis for Microglial Metabolic Fitness
- Soluble TREM2 (sTREM2) as Therapeutic Mimic — Decoupling Phagocytosis from Inflammation